MY138085A - Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them - Google Patents

Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them

Info

Publication number
MY138085A
MY138085A MYPI20033346A MYPI20033346A MY138085A MY 138085 A MY138085 A MY 138085A MY PI20033346 A MYPI20033346 A MY PI20033346A MY PI20033346 A MYPI20033346 A MY PI20033346A MY 138085 A MY138085 A MY 138085A
Authority
MY
Malaysia
Prior art keywords
alkyl
aryl
heteroaryl
medicaments
pharmaceutical compositions
Prior art date
Application number
MYPI20033346A
Inventor
Lesuisse Dominique
Dutruc-Rosset Gilles
Halley Franck
Babin Didier
Rooney Thomas
Tiraboschi Gilles
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MY138085A publication Critical patent/MY138085A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

THE PRESENT INVENTION RELATES TO NOVEL DERIVATIVES OF GENERAL FORMULA (I)(I)IN WHICHR3 IS A (1-6C) ALKYL, ARYL, ARYL(1-6C) ALKYL, HETEROARYL, HETEROARYL (1-6C) ALKYL,ARYL OR HETEROARYL FUSED TO A (1-10C) CYCLOALKYL, HETEROCYCLE, HETEROCYCLOALKYL, CYCLOALKYL, ADAMANTYL, POLYCYCLOALKYL, ALKENYL, ALKYNYL, CONR1 R2, COOR1, SO2 R1, C(=NH) R1 OR C(=NH)NR1 RADICAL;R5 , R6 AND R7 ARE, INDEPENDENTLY OF ONE ANOTHER, CHOSEN FROM THE FOLLOWING RADICALS: HALOGEN, CN,NO2,NH2, OH, OR8, COOH, C(O)OR8, -O-C(O)R8, NR8 R9, NHC 9O) R8, C(O)NR8 R9, NHC (S) R8, C(S)NR8 R9, SR8, S(O) R8, SO2 R8, NHSO2 R8, SO2 NR8 R9, -O-SO2 R8, -SO2-O-R8, TRIFLUOROMETHYL, TRIFULOROMETHOXY, (1-6C) ALKYL, (1-6C) ALKOXY, ARYL, ARYL (1-6C) ALKYL, HETEROARYL, HETEROARYL (1-6C) ALKYL,HETEROCYCLE, CYCLOALKYL, ALKENYL, ALKYNYL, ADAMANTYL OR POLYCYCLOALKYL.
MYPI20033346A 2002-12-12 2003-09-04 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them MY138085A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0215720A FR2848554A1 (en) 2002-12-12 2002-12-12 New aminoindazole derivatives are kinase inhibitors, useful in the treatment of neurodegenerative diseases, obesity, metabolic disorders, diabetes, hypertension, polycystic ovarian syndrome, cancers and other disorders

Publications (1)

Publication Number Publication Date
MY138085A true MY138085A (en) 2009-04-30

Family

ID=32338720

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20033346A MY138085A (en) 2002-12-12 2003-09-04 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them

Country Status (11)

Country Link
JP (1) JP4764168B2 (en)
CN (2) CN101979382A (en)
AR (1) AR041132A1 (en)
AT (1) ATE520399T1 (en)
FR (1) FR2848554A1 (en)
ME (1) MEP25308A (en)
MY (1) MY138085A (en)
PE (2) PE20040996A1 (en)
RS (1) RS20050421A (en)
TW (1) TWI345561B (en)
ZA (1) ZA200504681B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007002717A1 (en) 2007-01-18 2008-07-24 Merck Patent Gmbh Heterocyclic indazole derivatives
DE102007022565A1 (en) 2007-05-14 2008-11-20 Merck Patent Gmbh Heterocyclic indazole derivatives
AR075594A1 (en) * 2009-02-26 2011-04-20 Glaxo Group Ltd DERIVATIVES OF (2-TIENIL) -SULFONIL-AMINO-1H-INDAZOL AS AN ANTIGONIST OF CCR4
EP3309163A4 (en) 2015-06-15 2019-01-09 UBE Industries, Ltd. SUBSTITUTED DIHYDROPYRROLOPYRAZOLE DERIVATIVE
CN115260165B (en) * 2021-04-29 2024-08-06 中国科学院上海药物研究所 Benzo nitrogen-containing five-membered heterocyclic compound and synthesis and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51143010A (en) * 1975-06-04 1976-12-09 Kao Corp Stable bleaching detergent composition
DK1318997T3 (en) * 2000-09-15 2006-09-25 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors
US6593349B2 (en) * 2001-03-19 2003-07-15 Icagen, Inc. Bisarylamines as potassium channel openers
ES2357502T3 (en) * 2001-09-26 2011-04-27 Pfizer Italia S.R.L. ACTIVE AMINOINDAZOL DERIVATIVES AS QUINASE INHIBITORS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2836915B1 (en) * 2002-03-11 2008-01-11 Aventis Pharma Sa AMINOINDAZOLE DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
WO2004022544A1 (en) * 2002-09-05 2004-03-18 Aventis Pharma S.A. Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
TWI345561B (en) 2011-07-21
CN101979382A (en) 2011-02-23
ATE520399T1 (en) 2011-09-15
RS20050421A (en) 2007-08-03
PE20040996A1 (en) 2005-01-28
ZA200504681B (en) 2006-08-30
TW200422293A (en) 2004-11-01
CN1713909A (en) 2005-12-28
JP4764168B2 (en) 2011-08-31
MEP25308A (en) 2010-06-10
JP2006516266A (en) 2006-06-29
FR2848554A1 (en) 2004-06-18
PE20091629A1 (en) 2009-11-16
AR041132A1 (en) 2005-05-04

Similar Documents

Publication Publication Date Title
MY138269A (en) Aminoindazole derivatives, preparation process and intermediates of this process as medicinal products, and pharmaceutical compositions containing them
CY1111075T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING THE PRODUCTS OF 3-AMINO-AZETIDINE, THEIR NEW PRODUCTS, AND THEIR PREPARATION
PL412704A1 (en) Derivatives of phosphonooxyquinazoline their compositions and pharmaceutical application
NO20071140L (en) New piperidine derivatives such as histamine H3 receptor ligands for the treatment of depression
CA2445190A1 (en) Indole, azaindole and related heterocyclic amidopiperazine derivatives
HUP0302485A2 (en) Arylmethylamine derivatives for use as tryptase inhibitors and pharmaceutical compositions containing them
HUP0300203A2 (en) Novel cyclic amide derivatives, and pharmaceutical compositions containing same
EA200600364A1 (en) DERIVATIVES (TIO) OF CARBAMOILCYCLOGEXANE AS ANTAGONISTS D / D RECEPTOR
DE60010076D1 (en) CHINOLINE DERIVATIVES AS AN ANTIBACTERIAL AGENTS
HUP0402310A2 (en) 1,6-naphthyridine derivatives as antidiabetics and pharmaceutical compositions containing them
AR034203A1 (en) DERIVATIVES OF 1-ARIL- OR 1-ALQUILSULFONILBENZAZOL AS LIGANDS OF 5-HYDROXITRIPTAMINE-6, A METHOD FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
WO2004018475A3 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
HUP0002353A2 (en) 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phoshodiesterase iv inhibitory activity and pharmaceutical compositions containing them
DE602007005811D1 (en) 6-SUBSTITUTED ISOCHINOLINE DERIVATIVES AS ROCK-1 INHIBITORS
RU2009144538A (en) NEW CYCLIC PEPTIDE COMPOUNDS
MY130411A (en) Piperidine derivatives
DE69924292D1 (en) PYRAZOL COMPOUNDS AND ITS USE
SE0101579D0 (en) New compounds
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
IL180495A (en) Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
EA200700901A1 (en) DERIVATIVES 2-AMIDO-4-PHENYL THIAZOLE, THEIR OBTAINING AND USE IN THERAPY
ATE482933T1 (en) SULFOPYRROL DERIVATIVES
MY138085A (en) Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
WO2003066621A8 (en) Piperidine derivatives and their use as antagonists of tachykinins
MY140653A (en) Substituted diketopiperazines and their use as oxytocyn antagonists